Human Hepatitis B Immunoglobulin (Wuhan Institute of Biological Products)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHuman Hepatitis B Immunoglobulin (Wuhan Institute of Biological Products)
Drug Alias Name人乙型肝炎免疫球蛋白-武汉生物制品研究所
ClassificationBiologics > Blood componentsBiologics > Protein drugs > Immunoglobulin
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsHepatitis B
Approved Indications in ChinaHepatitis B
Original Approved Country/TerritoryMainland China
Original Approved Date1999/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesWuhan Institute Of Biological Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWuhan Institute Of Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeJ06BB04
Related LinksN/A